Vaginismus Treatments
Links shared publicly online about this topic
Female sexual dysfunction treatment options | KevinMD.com
kevinmd.com — “Female sexual dysfunction has been reported in up to 40% of women, and described as causing actual distress in approximately 12% of women. Here are some treatments.” View full resource at kevinmd.com
Most Recently Shared on May 27, 2010 at 7:01 pm By:
JillofAllTrades,MD Doctor, Family Medicine Doctor, and Physician
thx for RT! @Steplor Discussion of diagnosis & treatment options for female sexual dysfunction http://ow.ly/20xJG (via @kevinmd)
Modern Love: Sex, Relationships & Your Health: Vaginismus Treatments Done Differently
blogs.webmd.com — “The leading source for trustworthy and timely health and medical news and information. providing credible health information, supportive community, and educational services by blending award-winning expertise in content, community services, expert commentary, and medical review.” View full resource at blogs.webmd.com
Most Recently Shared on February 25, 2008 at 9:15 pm By:
Vaginismus Treatments Done Differently http://tinyurl.com/37e7dr
Washington Post Opinion Article Responds To Critics Of Female Sexual Dysfunction Drug
medicalnewstoday.com — “Claims that the development of a drug to treat female sexual dysfunction amounts to disease mongering come down to a delicate judgment call -- that lack of female sexual satisfaction isn't reall” View full resource at medicalnewstoday.com
Most Recently Shared on June 10, 2010 at 12:37 pm By:
Women's Health Line Health Site
Washington Post Opinion Article Responds To Critics Of Female Sexual Dysfunction Drug http://w.sns.ly/02e45 #womenshealth
Advisory Panel Says FDA Should Not Approve Drug To Address Female Sexual Dysfunction
medicalnewstoday.com — “On Friday, an FDA advisory panel voted 11-0 against recommending FDA approval of a proposed treatment for hypoactive sexual-desire disorder, which decreases women's sex drive, the” View full resource at medicalnewstoday.com
Most Recently Shared on June 22, 2010 at 3:44 pm By:
Advisory Panel Says FDA Should Not Approve Drug To Address Female Sexual Dysfunction: On Friday, an FDA advisory p... http://mnt.to/f/3FbY
Articles Analyze Debate Surrounding Female Sexual Dysfunction Drug Flibanserin
medicalnewstoday.com — “The Los Angeles Times and New York Times recently examined issues related to the experimental female libido drug flibanserin. On June 18, an FDA advisory panel voted 11-0” View full resource at medicalnewstoday.com
Most Recently Shared on June 30, 2010 at 12:59 pm By:
Articles Analyze Debate Surrounding Female Sexual Dysfunction Drug Flibanserin: The Los Angeles Times and New York... http://mnt.to/f/3FxV
Enrollment commences in Palatin's bremelanotide Phase 2b trial for female sexual dysfunction
news-medical.net — “Palatin Technologies, Inc. announced today that enrollment of patients has commenced in Palatin's Phase 2b clinical trial evaluating the efficacy and safety of bremelanotide (previously called PT-141), an on-demand, first-in-class melanocortin agonist being developed for the treatment of female sexual dysfunction (FSD).” View full resource at news-medical.net
Most Recently Shared on June 28, 2011 at 9:28 pm By:
Enrollment commences in Palatin's bremelanotide Phase 2b trial for female sexual dysfunction: Palatin Technologi... http://bit.ly/m5QT6f
A Viagra for Women? Female Sexual Dysfunction in Spotlight - ABC News
abcnews.go.com — “Attempts to treat female sexual dysfunction with Pfizer's erectile dysfunction drug Viagra have been largely unsuccessful, but a new prototype from the company offers hope for a female-specific treatment for those with Female Sexual Arousal Disorder (FSAD).” View full resource at abcnews.go.com
Most Recently Shared on April 14, 2010 at 1:23 pm By:
HealthIT Policy Health IT and Health News
A Viagra for Women? Animal Study Shows Promise: New research sheds light on how to treat female sexual dysfuncti... http://bit.ly/9JJ6cy
International Journal of Impotence Research - Motivations for seeking treatment for ED: the woman's perspective
nature.com — “International Journal of Impotence Research: The Journal of Sexual Medicine is a print and online publication dedicated to providing the latest research in the field of sexual medicine including male and female sexual dysfunction as it relates to diabetes, cardiology, endocrinology, and primary care medicine” View full resource at nature.com
Most Recently Shared on March 29, 2011 at 8:40 pm By:
Health Literacy Medical School
#Motivations for seeking treatment for Erectile Dysfunction: the woman's perspective http://ht.ly/4hY0T
International Journal of Impotence Research - Safety and efficacy of tamsulosin in the treatment of painful ejaculation: a randomized, double-blind, placebo-controlled study
nature.com — “International Journal of Impotence Research: The Journal of Sexual Medicine is a print and online publication dedicated to providing the latest research in the field of sexual medicine including male and female sexual dysfunction as it relates to diabetes, cardiology, endocrinology, and primary care medicine” View full resource at nature.com
Most Recently Shared on April 12, 2011 at 3:00 am By:
Health Literacy Medical School
Treatment of painful #ejaculation - Safety & efficacy of tamsulosin http://ht.ly/4wUa1
FDA OKs study of Botox to ease sex - In Your Face : The Orange County Register
inyourface.ocregister.com — “FDA okays study of Botox to ease sex | sexual intercourse, vaginismus, treatment, therapy, clinical trial, vagina, consummation, marriage, gynecologist” View full resource at inyourface.ocregister.com
Most Recently Shared on October 13, 2010 at 7:42 pm By:
Kinsey Institute Health Organization
FDA OKs study of Botox to ease sex - In Your Face : The Orange County Register http://t.co/m62JMjI
Palatin reports positive results from bremelanotide Phase 1 trial for sexual dysfunction
news-medical.net — “Palatin Technologies, Inc. today announced positive results of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD). The results demonstrate that with subcutaneous administration consistent therapeutic blood plasma levels can be obtained without sustained clinically significant blood pressure effects and support the continued development of bremelanotide.” View full resource at news-medical.net
Most Recently Shared on August 17, 2010 at 4:56 pm By:
Palatin reports positive results from bremelanotide Phase 1 trial for sexual dysfunction: Palatin Technologies, In... http://bit.ly/a6mf0H
BioSante Pharmaceuticals Completes Enrollment In LibiGel(R) Phase III Efficacy Trial - QualityPoint Technologies
qualitypointtech.net — “BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced that enrollment of subjects in the first of two pivotal Phase III LibiGel (testosterone gel) safety and efficacy trials has been completed. The efficacy trials are being conducted under an FDA-approved special protocol assessment (SPA) agreement. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved produc” View full resource at qualitypointtech.net
Most Recently Shared on February 27, 2011 at 8:00 pm By:
BioSante Pharmaceuticals Completes Enrollment In LibiGel(R) Phase III Efficacy Trial: BioSante Pharmaceuticals, In... http://bit.ly/gAr0JQ
BioSante Pharmaceuticals Reaches Key LibiGel(R) Safety Study Enrollment Target
medicalnewstoday.com — “BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important en” View full resource at medicalnewstoday.com
Most Recently Shared on October 19, 2010 at 3:37 pm By:
Women's Health Line Health Site
BioSante Pharmaceuticals Reaches Key LibiGel(R) Safety Study Enrollment Target http://sns.ly/iAU52 #womenshealth
Enrollment complete in BioSante's LibiGel Phase III cardiovascular and breast cancer safety study
news-medical.net — “BioSante Pharmaceuticals, Inc., today announced completion of enrollment in its ongoing LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.” View full resource at news-medical.net
Most Recently Shared on May 31, 2011 at 5:09 pm By:
Enrollment complete in BioSante's LibiGel Phase III cardiovascular and breast cancer safety study: BioSante Phar... http://bit.ly/lLO03h
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
JillofAllTrades,MD
Family Medicine doc. Silly blogger. Patient education advocate. Obsessed with music. Traveler.
-
WebMD_Blogs
Better information. Better health.
-
Women's Health Line
The latest women's health news and research.
Advertisement
